Subscribe to RSS Feed
Mundipharma receives positive CHMP opinion for oxycodone / naloxone combination for the treatment of restless legs syndrome1
Dublin, 25 November 2014 – Mundipharma recently announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
REPORT: Patients suffering from medicines shortages in all European countries
A new report on medicines shortages experienced in European healthcare systems reveals that over 86% of hospital pharmacists are experiencing difficulties in...
Key research from the inaugural 2014 palliative care in oncology symposium highlights advances in integrating palliative care into treatment and financial hardships facing people living with cancer
ALEXANDRIA, Va. – Four studies from the inaugural 2014 Palliative Care in Oncology Symposium were highlighted today in an embargoed presscast for reporters....
CTI and Independence Blue Cross study in Health Service Research finds fewer emergency room visits for chronically ill patients treated in patient-centered medical homes
Largest study of its kind shows nearly an 8 percent reduction in emergency visits, primarily for those with diabetes, heart disease and high blood pressure
Is Europe putting cancer research at risk?
Lugano, Switzerland, 25 July 2014. The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology...
Tough decision for Roche following mixed Phase II Trial results for Alzheimer’s drug, says GlobalData Analyst
• Roche faces difficult decision over entering Alzheimer’s disease (AD) drug crenezumab for Phase III clinical trials
EAHP: Apps involving medicines should have pharmacist oversight
The European Association of Hospital Pharmacists (EAHP) has responded to a consultation by the European Commission
ESMO 16 World GI Press Release: International phase III trial shows survival benefit of MM-398 added to standard treatment in post-gemcitabine metastatic pancreatic cancer
Barcelona/Lugano -- Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves...
Pooled analysis of two Phase III Trials shows Halaven® (Eribulin) improves survival in advanced breast cancer
Significant survival benefit observed in women with HER2 negative breast cancer
Hospital pharmacists express concern to EMA about access to clinical trial information
The European Association of Hospital Pharmacists (EAHP) has written to the Board of the European Medicines Agency (EMA) expressing concern about proposals to...
British Cardiovascular Society response to open letter concerning NICE draft guidance on statins
The British Cardiovascular Society would like to highlight that the letter sent to NICE regarding their draft lipid guidance, by a number of healthcare...
Lenvatinib Phase III results show significant improvement in progression-free survival in people with Radioiodine-Refractory differentiated Thyroid Cancer
Pivotal phase III data for lenvatinib to be presented in a Head and Neck Cancer oral session at American Society of Clinical Oncology congress (ASCO)
ASCO issues new physician & patient resources on managing obesity-related challenges after a cancer diagnosis
New Tools Are Part of ASCO's Efforts to Address Obesity as a Major Factor in the Nation's Cancer Burden
One Week until The European Summit on Hospital Pharmacy
Next week (14-15 May) a unique event will bring together representatives of hospital pharmacy from 34 countries, alongside spokespeople for a broad range of...
19th Congress of the EAHP looks to the future hospital pharmacist in 2020
A major talking point of last week’s Congress of the EAHP in Barcelona was the future roles and competencies for hospital pharmacists in the year 2020 and...